We used Western blotting to detect the downregulated expression of WTAP in endometrial cancer stem cells compared to that in Ishikawa cells, while other stem cell indicators, such as CD44, CD133, SOX2 and NANOG, were upregulated in ECSCs (Fig. 1H). This evidence concerns the gene WTAP and endometrial cancer.